John D. Shaughnessy
Corporate Officer/Principal bei University of Arkansas for Medical Sciences
Profil
John D.
Shaughnessy is the founder of Signal Genetics, Inc. which was founded in 2010.
He is currently the Director-Myeloma Institute for Research & Therapy at the University of Arkansas for Medical Sciences.
Dr. Shaughnessy holds a doctorate degree from the University of Maryland.
Aktive Positionen von John D. Shaughnessy
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Arkansas for Medical Sciences | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von John D. Shaughnessy
| Unternehmen | Position | Ende |
|---|---|---|
Signal Genetics, Inc.
 Signal Genetics, Inc. Medical/Nursing ServicesHealth Services Signal Genetics, Inc. is a commercial stage, molecular diagnostic company. It provides innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in January 2010 and is headquartered in Carlsbad, CA. | Gründer | - |
Ausbildung von John D. Shaughnessy
| University of Maryland | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Signal Genetics, Inc.
Signal Genetics, Inc. Medical/Nursing ServicesHealth Services Signal Genetics, Inc. is a commercial stage, molecular diagnostic company. It provides innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in January 2010 and is headquartered in Carlsbad, CA. | Health Services |
